Profil
Aaron Tward is the founder of Affinia Therapeutics, Inc., founded in 2019.
Dr. Tward currently holds the positions of Associate Professor at The University of California, San Francisco since 2022 and Chief Scientific Officer at Akouos, Inc. since 2022.
Dr. Tward earned a doctorate degree from The University of California, San Francisco.
Aktiva positioner av Aaron Tward
| Företag | Position | Start |
|---|---|---|
| AKOUOS | Teknisk/Vetenskaplig/F&U Direktör | 2022-03-10 |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | 2022-03-01 |
Tidigare kända positioner av Aaron Tward
| Företag | Position | Slut |
|---|---|---|
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Grundare | - |
Aaron Twards utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akouos, Inc.
Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
















